spacer
home > pmps > summer 2018 > driving digitalisation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Driving Digitalisation

Pharmaceutical manufacturers are faced with the task of bringing new drugs to market as quickly as possible, without any compromise on quality or patient safety. A key driver of this demand is the time pressure faced in relation to the expiry of patents. Therefore, manufacturers need to move from R&D to production in the shortest possible time with minimum investment. Digitalisation and the adoption of emerging industrial digital technologies are set to play key parts in the delivery of such objectives.

Digitalisation is the technology focus behind Industry 4.0, and the central message about how it can enhance manufacturing and production capabilities is gaining steady traction. Advocates say its data-driven, highly connected world of seamless technology platforms will drive productivity improvements, promote agile production, aid competitiveness, and, ultimately, build business value and boost economic success.

The recent publication of the government-backed Made Smarter Review has set out a clear road map for the wide-scale adoption of emerging industrial digitalisation technologies and articulates how this can have a significant and positive economic impact. This includes a predicted £455 billion boost for the UK’s manufacturing base, an increase in manufacturing sector growth of up to 3% per annum, a net gain of 175,000 jobs, and a reduction of CO2 emissions by 4.5%.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Alwyn Jones has over 20 years’ experience in automation and engineering, working with market-leading companies, supplying systems and solutions into the highly regulated industry sectors. At Siemens, he is Head of Pharmaceutical and Life Sciences and manages the UK and Ireland pharmaceutical and life sciences sector strategy, helping manufacturers bring new and affordable drugs to market in the shortest possible time, without any compromise on quality.
spacer
Alwyn Jones
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo sponsored the carriage of historical artifacts from the Topkapı and Dolmabahçe Palaces to Japan

Turkish Cargo, the air cargo brand of Turkish Airlines that provides service to 124 countries, carried 186 historical artifacts, owned by Dolmabahçe and Topkapı Palaces, to Tokyo, the capital of Japan, as the sponsor carrier, in order to be displayed at the exhibition titled as "The Ottoman Empire and Tulip Culture" held as part of the events organized for 2019 which was declared as the "Year of Turkish Culture" across Japan.
More info >>

White Papers

Recommendations for Implementing Assessment Criteria Guidelines in Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

Perceptive Informatics

Standardized assessment criteria are becoming increasingly important in obtaining valid outcomes in oncology clinical trials. While standardized criteria encourage a more uniform approach to assessing clinical trial data, they are often subject to the interpretation of the user. These differences in interpretation, while seemingly minor, can have a major impact on assessments. The most commonly used standardized criteria for lymphoma have been no exception. Differences such as minimum new lesion size, lymph node normalization size requirements, inclusion of extranodal lesions and assessment of organomegaly can have a profound effect on overall response. Additionally, heightened scrutiny of the assessment criteria used in a given protocol can lead to questions about a drug’s efficacy if not applied correctly according to regulators’ interpretation.
More info >>

 
Industry Events

ASGCT 22nd Annual Meeting

29 April - 2 May 2019, Washington Hilton, Washington, D.C

The 2019 ASGCT Annual Meeting is expected to be the largest in Society history, eclipsing the mark set by the 2018 meeting just last year. Join more than 3,500 researchers, clinicians, advocates, and industry leaders in discovering the latest science and technology surrounding gene and cell therapy.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement